| ISIN | LU1585228882 |
|---|---|
| Valorennummer | |
| Bloomberg Global ID | |
| Fondsname | Bellevue Emerging Markets Healthcare I EUR |
| Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fondsanbieter | Bellevue Asset Management AG |
| Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
| Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
| Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
| Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
| Besonderheiten |
| Aktueller Preis * | 130.30 EUR | 20.01.2026 |
|---|---|---|
| Vorheriger Preis * | 132.77 EUR | 19.01.2026 |
| 52 Wochen Hoch * | 141.34 EUR | 08.10.2025 |
| 52 Wochen Tief * | 107.99 EUR | 09.04.2025 |
| NAV * | 130.30 EUR | 20.01.2026 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 44'451'138 | |
| Anteilsklassevermögen *** | ||
| Trading Information SIX | ||
| YTD-Performance | +4.14% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
|---|---|---|
| YTD-Performance (in CHF) | +3.56% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
| 1 Monat | +2.00% |
22.12.2025 - 20.01.2026
22.12.2025 20.01.2026 |
| 3 Monate | -3.39% |
20.10.2025 - 20.01.2026
20.10.2025 20.01.2026 |
| 6 Monate | -1.02% |
21.07.2025 - 20.01.2026
21.07.2025 20.01.2026 |
| 1 Jahr | +9.03% |
20.01.2025 - 20.01.2026
20.01.2025 20.01.2026 |
| 2 Jahre | +4.86% |
22.01.2024 - 20.01.2026
22.01.2024 20.01.2026 |
| 3 Jahre | -19.94% |
20.01.2023 - 20.01.2026
20.01.2023 20.01.2026 |
| 5 Jahre | -42.25% |
15.06.2021 - 20.01.2026
15.06.2021 20.01.2026 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Celltrion Inc | 7.26% | |
|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 6.65% | |
| BeOne Medicines Ltd Ordinary Shares | 6.62% | |
| Samsung BioLogics Co Ltd | 5.69% | |
| Innovent Biologics Inc | 5.42% | |
| WuXi Biologics (Cayman) Inc | 5.06% | |
| Akeso Inc Ordinary Shares | 3.78% | |
| Sino Biopharmaceutical Ltd | 3.34% | |
| Cipla Ltd | 3.15% | |
| CSPC Pharmaceutical Group Ltd | 2.97% | |
| Letzte Daten-Aktualisierung | 31.12.2025 | |
| TER | 1.58% |
|---|---|
| Datum TER | 29.01.2021 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 0.90% |
| Ongoing Charges *** | 1.42% |
|
SRRI ***
|
|
| Datum SRRI *** | 31.12.2025 |